Avantor (NYSE:AVTR) had its price target lifted by Raymond James from $17.00 to $23.00 in a report published on Thursday, BenzingaRatingsTable reports. Raymond James currently has an outperform rating on the stock.
AVTR has been the topic of a number of other research reports. Stifel Nicolaus lifted their target price on Avantor from $15.00 to $18.00 and gave the company a hold rating in a research report on Thursday, April 30th. UBS Group decreased their target price on Avantor from $22.00 to $20.00 and set a buy rating on the stock in a research report on Tuesday, April 28th. Credit Suisse Group lifted their target price on Avantor from $18.00 to $21.00 and gave the company an outperform rating in a research report on Tuesday, July 28th. Zacks Investment Research cut Avantor from a buy rating to a hold rating in a research report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. lifted their target price on Avantor from $18.00 to $25.00 and gave the company an overweight rating in a research report on Thursday. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Avantor has an average rating of Buy and an average price target of $20.65.
Shares of NYSE AVTR opened at $22.08 on Thursday. Avantor has a 52 week low of $6.66 and a 52 week high of $22.29. The stock has a market capitalization of $12.73 billion, a P/E ratio of 96.00, a PEG ratio of 1.66 and a beta of 2.01. The stock’s fifty day moving average is $17.98 and its 200 day moving average is $16.48.
Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.19 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.05. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.49 billion. During the same quarter in the previous year, the business posted $0.14 EPS. The firm’s revenue for the quarter was down 3.5% on a year-over-year basis. Research analysts anticipate that Avantor will post 0.74 earnings per share for the current year.
In related news, Director Jo Natauri sold 13,726,411 shares of Avantor stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $15.90, for a total value of $218,249,934.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Devashish Ohri sold 65,000 shares of Avantor stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $18.84, for a total value of $1,224,600.00. Following the completion of the transaction, the executive vice president now directly owns 181,671 shares in the company, valued at $3,422,681.64. The disclosure for this sale can be found here. Insiders have sold 34,726,317 shares of company stock worth $552,420,898 over the last three months. Insiders own 1.90% of the company’s stock.
Several institutional investors have recently bought and sold shares of the stock. Viking Global Investors LP lifted its stake in shares of Avantor by 20.5% in the first quarter. Viking Global Investors LP now owns 10,050,838 shares of the company’s stock worth $125,535,000 after acquiring an additional 1,706,772 shares during the period. Eminence Capital LP lifted its stake in shares of Avantor by 538.5% in the first quarter. Eminence Capital LP now owns 5,915,718 shares of the company’s stock worth $73,887,000 after acquiring an additional 4,989,199 shares during the period. Maverick Capital Ltd. lifted its stake in Avantor by 54.4% in the first quarter. Maverick Capital Ltd. now owns 5,625,123 shares of the company’s stock valued at $70,258,000 after buying an additional 1,980,755 shares during the period. Norges Bank acquired a new position in Avantor in the fourth quarter valued at approximately $66,866,000. Finally, New South Capital Management Inc. acquired a new position in Avantor in the first quarter valued at approximately $38,272,000. 78.90% of the stock is currently owned by institutional investors.
Avantor, Inc is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services.
Read More: How is the Producer Price Index calculated?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.